Pelago vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Pelago is the world's leading virtual clinic for substance use management; has helped 750K+ members manage tobacco, alcohol, and opioid use; delivers $6,758 in employer savings per member with 4.5:1 ROI.
About
Pelago is a virtual healthcare company and the world''s leading digital clinic for substance use management (SUM). Founded and headquartered in the United States, Pelago partners with employers, health plans, and consultants to provide evidence-based, clinician-led treatment for employees struggling with tobacco, alcohol, and opioid use — covering the full spectrum from prevention and education to active treatment. The company is backed by Y Combinator and has served more than 750,000 members across the United States.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.